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The measurements of HLA class I and II antigen expres-
sions were made in association with assessment of antipro-
liferation effects on cancer cells. 
 Experiments were designed to measure HLA class I and 
II expressions by using flow cytometry in the mixed culture 
of WiDr cells, OK-432 and peripheral lymphocytes. 
 The result showed that proliferation of cancer cells was 
suppressed in contact with OK-432, indicating augmented 
HLA class I and II antigen expression. It was suggested of 
activation of immunocompetent cells as well as induction 
of HLA antigen expression. 
 HLA class I and II antigen expressions were clinically 
eveluated in patients with gastric cancer between with and 
with-out local administration of OK-432. Cancer tissues 
were fixed by to AMeX method and immunohisto-
chemically stained by ABC method. The degrees of HLA 
class I antigen expressions were depressed in accordance 
with cancer progression. In contrast, they were seen in the 
majority of patients in this study. On the other hand, HLA 
class II antigen expressions were reduced (p < 0.05) with 
cancer progression, the increase in cancer infiltration and 
the decrease in differentiation. 
 It was suggested that reduction of HLA-class II (DR) 
antigen expression be in association with biologically 
malignant potential. 
  In addition, it was assumed that local administration of 
OK-432 enabled HLA class II antigen expression and 
lymphocyte infiltration around the tumor to enhance even 
in patients with advanced and undifferentiated cancers and 
it was suggested that OK-432 made it possible to induce 
tumor immunity and to become a valid method of postop-
erative immunotherapy.
Introduction 
It is known that the activation of CTL and helper T in 
tumor-bearing host necessitates MHC and HLA antigen 
expression, recognizing tumor-specific antigens.'"' The 
possibility exists that proliferation of cancer cells and 
promotion of metastasis are in association with suppression 
of HLA antigen expression.'-")
 In this experimental study, it was aimed at elucidating a 
correlation with interaction of host immunity and prolif-
erative cancer cells. 
 In this series, the cytocidal effect of immunocompetent 
cells was experimentally evaluated in relation to HLA class 
I and II antigen expressions. In cotrast, HLA class I and II 
antigen expression was immunohistochemically compared 
with hostopathologic factors. The effects of OK-432 on 
HLA class I and class II antigen expressions were assessed 
in comparison with Tumor-infiltrating lymphocytes (TIL).
Material and Method 
Experiment 1: 
HLA antigen expression in cultured cells and response to 
immunocompetent cells. 
  WiDr cells originated from colon cancer cells were used 
as a target cell and peripheral blood lymphocytes (PBL) as 
an effector cell. And BRM of OK-432, rHu IFN, anti-
IFN7 Ab was used. MoAb of W6/32 (anti-HLA-class I) 
and of Tal 1 B5 (anti-HLA-class II) were selected. 
 Method (1) WiDr cells were cultured in MEM, divided 
into 4 groups by the addition of PBL (E:T = 2:1), OK-432 
0.1KE/ml and rHuIFN IOu/ml and mixcultured for 48 to 96 
hours at 37C in 5% CO2. Cells were counted, added mouse 
serum to interfere with non-specific reaction, contacted 
with MoAb, followed by FITC conjugated anti-mouse IgG 
Ab. In each step, the sample was rinsed with PBS, and 
centrifuged twice. The amount of fluorescence of HLA 
antigen expression on the surface of cells was measured by 
using flow cytometry (FACS IV). 
 (2) 1 X 106 WiDr cells were taken and effector cells 
were prepared by excluding macrophages with adherence 
method. The samples were divided into three groups, con-
trol (E:T = 2:1), OK-432 0.1 KE/ml (E:T = 2:1), and 
OK-432 0.1KE/ml (exclusion of MO), cultured for 72 to 96 
hours and the fluorescence amount was measured by flow 
cytometry according to indirect detection of fluorescent 
antibody method.'' 
 (3) 1 X 106 WiDr cells were divided into three groups:
control, in contact with OK-432 0.1 KE/ml and OK-432 
O.IKE/ml adding anti-INFy antibody, respectively. The 
samples were cultured for 72 to 96 hours. And also flow 
cytometry was used for the measurement of fluorescence. 
 (4) The IFNy titers were measured in a mixed culture of 
WiDr cells with OK-432, PBL and IFNy. 
Experiment 2: 
HLA antigen expression in resected gastric cancer tissues. 
1. Subject (Table 1) 
The gastric cancer tissues resected at the First Dept. of 
Surgery, Nagasaki University Hospital and its affiliated 
hospitals were subjected to this study in which 15 were 
OK-432 injected cases and the other 33 belonged to not 
injected. OK-432 was endoscopically given around the 
tumorous lesion 3 to 7 days prior to operation.
Table 1. Clinical background
          I local administration 
            of OK -432 15 cases II control 33 cases 
 age 38 to 81 (mean 61.2) 28 to 83 (63.7) 
 sex M/F = 9/6 M/F = 22/11 
histology 
 tub, 5 5 
 tube 1 13 
 por 7 15 
 sig 2 
stage 
 I 7 9 
 II 4 5 
 III 1 12 
 IV 3 7
2. Method (Table 2) 
Immediately after the resection of the tumor-bearing stom-
ach, tissues were paraffin-embeded. A part of slice was 
stained with HE and the others were immunohisto-
chemically stained according to Avidine-Biotin-complex 
method"' with the use of MoAb (anti-HLA-ABC, W6/32, 
anti-HLA-DR, TAL 1B5, DAKO JAPAN.) 
3. Estimation 
The stainings were regarded as (+) 25 to 50% staining, (++) 
50 to 75% (+++) over 75%. When compared with the 
positive control of Mq and the endothelium under light 
microseopic finding. TIL were graded as (++) definitively 
rich infiltrative cells, (+) similar degree, (±) scanty as 
compared with those in non-cancer tissues.
Table 2. Experimental protocol
I OK-432 local administration endoscopically given 0.4cc 
   diluted 2 .- 3ml of 5KE OK-432 in 5 sites of intra-and 
   around the tumors. 
II Sampling and treatment 
 © Slices of 2 --- 3mm 
 (2 4 °C in aceton for 30min 
 ® Overnight in -20T aceton 
 ® 4 °C in aceton for 15min 
 o Kept at room temperature in aceton 
 © Kept at room temperature in Methyl benzoate 
 o Kept at room temperature in Xylene 
 ® paraffin enbedded 
III histochemical staining 
 Ol 5,u slice 
 o deparaffinized with Xylen, Acetone 
 ® intrinsic peroxidase block 
 ® NSS at room temperature 
 ® contact with MOAbs at 4 °C overnight 
 © Second Ab (Biontinized) at room temperature 
  7Q ABC reaction at room temperature for 40min 
 ® Paraffin enbedded preparate 
ABC reaction 
DAB 




Proliferation of WiDr cells was suppressed in the mixed 
culture in contact with O.1KE/ml OK-432 and also HLA-
DR antigen expression was enhanced in proportion to the 
concentration of PBL as shown in Fig. 1. 
  In a mixed culture of lymphocytes and OK-432 after 
removal of MO, suppression of proliferation of WiDr cells 
was weakened accompanying less HLA-A•B•C•DR antigen 
expression as shown in Fig. 2 as compared with that of 
unpretreated PBL alone. On the other hand, in a mixed 
culture with OK-432 and PBL in contact with anti-IFNy . 
The proliferative curve of WiDr cells was almost the same 
as the control without enhancement of HLA antigen ex-
pression as shown in Fig. 3. 
 The IFNy titers in supernatant of culture medium were 
affected by culture medium, time duration of culture and 
PBL. In cotrast, the concentration of IFNy in the control 
remained stationary and it was less than 0.02u/ml in contact 
with PBL. And also no significant change in the concen-
tration of IFNy was seen regardless of the PBL concen-
tration and the time duration of contact. In contact with 
OK-432 0.1 KE/ml + PBL (E:T = 1:1), the IFNy concen-
tration showed 0.44 to 1.70u/ml and concentration with a 
96 hour contact. In case of contact with OK-432 0.1 KE/ml 
+ PBL (E:T = 2:1), the IFNy concentration was increased 
to 1.9 to 7.9u/ml, indicating a close correlation with the
Fig. 1. Cell proliferation and changes in HLA antigen by mixed 
culter with OK-432 and lymphocytes
Fig. 2. Changes in cell proliferation and HLA antigen expression 
by lymphocytes exclusive of m (D
concentration of PBL. Meanwhile, in case of contact with 
IFN y 10u/ml and PBL, the IFN y concentrations were 
significantly high, ranging 3.0 to 16u/ml, maintaining a 
high level as compared with those in the other groups. On 
the other hand, the IFN y levels were similar to the control 
(0.06 to 0.16/ml) contact with PBL after removal of M 0 as 
shown in Table 3.
Table 3. IFN y concentration in culter medium
         the control -0.02U/ml 
OK-432 0.IKE + PBL (E:T=1:1) 0.44 --- 1.70U/ml 
OK-432 0.1KE + PBL (E:T=2: 1) 1.9 - 7.9U/ml 
INF y 1OU/ml + PBL (E:T/l:1) 3.0 .- 16U/ml 
OK-432 0.1 KE + M ' (-) PBL 0.06 - 0.16U/ml
Fig. 3. Changes in cell growth and HLA antigen expression in 
contact with anti-INF y Ab
Experiment 2: 
 HLA A•B•C and DR antigen expression of gastric can-
cer tissues. 
(1) HLA antigen expression in relation to disease stages. 
(Fig. 4). 
The intensity of HLA-A•B•C antigen expressions were 
gradually reduced with progression of disease stages. In 
contrast, HLA-DR antigen expression was seen only in 
early gastric cancer of stage I and II.
Fig. 4. Relationship between HLA antigen expression and stages, 
TIL
Fig. 5. Relationship between HLA-antigen expression and differ-
entiation
(2) HLA antigen expression in relation to differentiation. 
(Fig. 5) 
HLA A•B•C antigen expressions were seen in almost all of 
well differentiated carcinomas. Even in undifferentiated 
carcinomas, the HLA ABC antigen expressions were seen 
in 8 out of 15 (53.3%) in spite of a decrease in their 
expressions. HLA DR antigen expression was shown in 4 
out of 5 (80%). In contrast, it was reduced in accordance 
with poor differentiation (p < 0.01) as shown in Fig. 5. 
(3) HLA antigen expression in relation to the depth of
cancer infiltration, invasive types and node metastasis. 
(Fig. 6, 7, 8) 
There was no close correlation with HLA-A•B•C antigen 
expression and the depth, invasive types nodal involve-
ment. On the other hand, a decrease in HLA DR antigen 
expression was seen in accordance with cancer progres-
sion. There was a significant difference (p < 0.05) in HLA 
DR expression between INF and n2n3. TIL was significant 
in some of stage I and II. However, there was no good 
correlation between TLL and HLA antigen expression.
Fig. 6. Relationship between the depth invasive types and HLA-antigen expression
Fig. 7. Relationship between n-factors lymphatic invasion and HLA-antigen expression
Local administration of OK-432 and HLA-A•B•C-DR anti-
gen expression 
(1) Relation between disease stages and HLA-A•B•C anti-
gen expression. (Fig. 4) 
HLA-A•B•C antigen expression were high in 10 out of 15 
(66.7%) in stage I and II. In contrast, these were reduced in 
one out of four (25%) in stage III and IV. On the other 
hand, HLA-DR antigen expression was seen in 12 out of 15 
(80%) and it was seen in three out of 4 (75%) even in stage 
III and IV, showing there was no difference between stage 
I and II. 
(2) Relation between differentiation and HLA antigen 
expression. (Fig. 5) 
HLA-A•B•C as well as HLA-DR antigens were well ex-
pressed in well and poorly differenciated carcinomas. Fig. 2. Early gastric cancer (well differentiated) 
  (left) HLA-ABC Ag, (right) HLA-DR Ag
Fig. 1. OK-432 0.1 KE/ml + PBL (E:T = 1:1) 72hr HLA-ABC 
Ag
Fig. 3. Advanced gastric cancer (poorly differentiated) 
    (left) HLA-ABC Ag, (right) HLA-DR Ag
Fig. 4. Advanced gastric cancer poorly differentiated OK-432 
locally given 
       (left) HLA-ABC Ag, (right) HLA-DR Ag
There were some of intensive expressions and cell infiltra-
tions in poorly differentiated carcinomas on occasion. (Fig. 
4) The grades of TIL had no close correlation with the 
grades of disease stage and differentiation, reflecting the 
fact that local injection of OK-432 produces a reflactory 
inflammation. These were enhanced in cases of positive 
expressions against HLA-A•B•C and DR antigen. As com-
pared with the control, HLA-DR antigen expressions were 
induced and immunologic cell infiltrations also were en-
hanced in the cases with local OK-432 injection.
Discussion 
It is accepted that immunotherapy is the most important 
tool to manage cancer patients with multimodality therapy. 
Recent studies" clarify that MHC and HLA antigen expres-
sions are essential for recognizing weak tumor-specific 
antigens and for having cytocidal effect of cytotoxic and 
helper T cells on cancer cells. 
  HLA antigens were divided into the two: class I and II 
antigens. Class I antigen exists in the nucleus and control 
cytotoxic T cell function"' and its expression is depressed 
and/or diminished with tumor progression of breast and 
renal cancers.'' 
 On the other hand, HLA class II (DR) antigen affects the 
function of helper T cells and it is expressed in the immu-
nocompetent cells such as macrophages and endothelial 
cells, in contrast, hardly seen in the normal cells.'- 18 'y' 
  In this study, HLA antigen expressions were evaluated in 
terms of histopathologic factors and host immunodefensive 
mechanism of TIL and also induction of HLA antigen 
expression was assessed by endoscopically local OK-432 
administration into gastric cancer tissues prior to operation. 
  HLA-antigen expressions on the cell surface were evalu-
ated to elucidate the influence of OK-432 and PBL as an
effector cells on cultured cells from the suppressive effect 
of proliferative cells. 
 It is well known that WiDr cells as a target cell used in 
this study have HLA-A•B•C antigen expression despite not 
having HLA-DR antigen expression which is enhanced by 
contact with IFN 7 in proportion to its concentration and 
result in suppressive effect of cell proliferation. And also it 
is defind that OK-432 activates macrophages, NK activity 
and IFN production.'' 
 Although the cytocidal effect by OK-432 was not clear 
in this study, HLA-antigen expressions were enhanced and 
cell proliferation was suppressed in a mixed culture with 
target cells. The maximum was 0.1 KE/ml of OK-432 in a 
72 hour culture .21,12) When exceeded the OK-432 concen-
tration of 0.1 KE/ml, these effects were in proportion to the 
rates of effector cells. 
 The mechanism of OK-432 cell-mediated effect is that 
OK-432 first activates macrophages and T cells are acti-
vated through its stimulation of IL-1, as a result, cytokines 
of IFN 7 and IL-2 were generated and finaly induced and 
enhanced HLA-class I.11 antigen expression. 
  In this study, there was no evidence that T cells directly 
attack target cells. However, it is suggested that M q5 and 
INF 7 plays more important role in activated cytocidal 
effect and suppressed cell proliferation rather than various 
cytokines.2" The roles of IFN 7 which is generated by 
helper T cells are augmentation of HLA-class I antigen 
expression, induction of HLA-class II antigen expression 
and activation of immunocompetent cells with varying 
variety as compared with IFNa, 8.24.151 
 The presence of INF 7 is indispensable for the function 
of antitumor immunity. It is said that helper T cells fail to 
recognize tumor cells but are capable for recognition of 
them. In spite of this fact, CTL alone are unable to recog-
nize tumor-associated antigen (TAA) and to represent 
cytocidal activity. At present, it is accepted that Mq first 
plays a key role in the response to TAA, and HLA-class II 
antigens are expressed on the surface of Mo and CD4-T 
cells, generating INF 7 of cytokine in activation of CTL, 
Mo and LAK. 
 There are many reports"") that the activation of helper T 
cells are an initial event of activated tumor-immunity. 
 In this study, it is clarified that Mo are activated with 
the help of OK-432 which is proportionate to its concen-
tration and they exert on helper T cells as an initial event in 
sequence of cytocidal effects. 
 It is emphasized that activation of helper T cell is 
mandatory for stimulation of Mo. OK-432 plays a main 
role in activation of T cells and also recognition of helper T 
cells and CTL, for tumor-antigen is essential for step of 
enhanced tumorimmunity. From a result of this exper-
imental study, it is defined that there is a close correlation 
between suppression of cell proliferation and HLA-class II 
antigen expression with help of IFN -1. 
 In the normal gastric mucosa, the HLA class I and II
antigens are expressed as it is consistent with the reports by 
Natali,79' David"' and Ghosh.31' There are no good corre-
lation among differentiation, the depth of cancer infil-
tration, invasive types and nodal involvement. It differs 
from a relationship with the prognosis in breast cancer, 
colon cancer and melanomas."" "I 
  On the other hand, Ferron32) pointed out a close corre-
lation between HLA-DR antigen expression and inflam-
matory cell infiltration. In this series, there is no good 
correlation between disease stages and HLA-DR antigen 
expression. 
 Recent studies clarified that T cells are activated with the 
help of MHC-antigen expression and TIL is induced with 
the help of HLA-DR antigen expression.33' In fact, compli-
cated environment exists in clinical case as the immuno-
suppressive state such as appearance of suppressor Mo. It 
is contemplated that HLA-DR antigen lies in the cell, not 
existing on the surface.35' In such a case, it is difficult to 
predict activated responses of tumor-immunity. This is the 
reason why the degrees of TIL are not necessarily propor-
tional to HLA-DR antigen expression. 
  Local OK-432 administration is of great effect in pro-
moting HLA-class I and II antigen expressions. Even in 
moderately differentiated carcinomas, HLA-DR antigen 
was uniformly expressed. 
  In the case of having uniformity of HLA-DR antigen 
expression, TIL was increased, including Mo infiltration 
in interstitial tissues. On the basis of the result of exper-
imental and clinical studies, it is emphasized that OK-432 
plays a role in enhancement of host mediated tumor-
immunity with the help of IFN -/. TIL findings well reflect 
activated tumor immunity. 
  And also it is assured that the procedures of local admin-
istration of OK-432 are of great benefit in clinical use in 
reflection of enhanced HLA-class I and II antigen expres-
sion.
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